HRT Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $966K | Sell |
42,080
-44,284
| -51% | -$1.02M | ﹤0.01% | 1084 |
|
|
2025
Q1 | $2.5M | Buy |
+86,364
| New | +$2.5M | 0.02% | 604 |
|
|
2024
Q2 | – | Sell |
-18,608
| Closed | -$817K | – | 1991 |
|
|
2024
Q1 | $817K | Buy |
+18,608
| New | +$817K | 0.01% | 937 |
|
|
2023
Q4 | – | Sell |
-10,057
| Closed | -$462K | – | 2103 |
|
|
2023
Q3 | $462K | Buy |
10,057
+4,028
| +67% | +$185K | ﹤0.01% | 1293 |
|
|
2023
Q2 | $346K | Sell |
6,029
-25,918
| -81% | -$1.49M | ﹤0.01% | 1402 |
|
|
2023
Q1 | $1.2M | Buy |
31,947
+14,254
| +81% | +$535K | 0.01% | 810 |
|
|
2022
Q4 | $495K | Buy |
+17,693
| New | +$495K | 0.01% | 1326 |
|
|
2022
Q3 | – | Sell |
-12,340
| Closed | -$429K | – | 2554 |
|
|
2022
Q2 | $429K | Buy |
+12,340
| New | +$429K | ﹤0.01% | 1736 |
|
|
2021
Q4 | – | Sell |
-14,315
| Closed | -$272K | – | 2826 |
|
|
2021
Q3 | $272K | Sell |
14,315
-21,733
| -60% | -$413K | ﹤0.01% | 2233 |
|
|
2021
Q2 | $726K | Buy |
+36,048
| New | +$726K | 0.01% | 1389 |
|
|
2020
Q3 | – | Sell |
-11,654
| Closed | -$261K | – | 1779 |
|
|
2020
Q2 | $261K | Buy |
+11,654
| New | +$261K | 0.01% | 927 |
|